-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2023 to Q3 2025.
- Neuphoria Therapeutics Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 30 Sep 2025 was $3,794,648, a 14% increase year-over-year.
- Neuphoria Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2025 was $77,229.
- Neuphoria Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $14,680,777, a 0.29% decline from 2023.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)